JVJean-Philippe Verhoye

Jean-Philippe Verhoye

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean-Philippe Verhoye has a total of 154 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management of Chronic Aortic Dissections After Type A: How and When to Reintervene

    by Jacques Tomasi, Pierre Escrig, Jean-Philippe Verhoye

    Acute Stanford type A aortic dissection is a surgical emergency with increasing survival due to advances in operative techniques. However, the majority of patients are left with a chronically dissected distal aorta – referred to as residual dissection after type A repair – which carries a substantial long-term risk of aneurysmal degeneration, rupture, and malperfusion. Up to 30–40% of survivors may require secondary interventions within two decades. Contemporary guidelines (ACC/AHA 2022, ESC 2024, EACTS/STS 2024) recommend lifelong surveillance, strict blood pressure control, and timely elective reintervention when defined thresholds are reached. Indications include aneurysm diameter ≥5.0–5.5 cm, rapid growth, new symptoms, or branch vessel malperfusion. Therapeutic options encompass open surgical reintervention, thoracic endovascular aortic repair (TEVAR), and hybrid approaches such as frozen elephant trunk, with choice tailored to anatomy, patient risk profile, and institutional expertise. Open surgery remains the gold standard in young and connective tissue disorder patients, offering durable exclusion of the false lumen, while TEVAR provides a less invasive alternative promoting favorable remodeling in selected anatomies. Hybrid strategies expand applicability in complex arch or thoracoabdominal disease. Outcomes have improved significantly in high-volume centers, with elective mortality in single digits and long-term survival comparable to nonreintervened patients. A multidisciplinary aortic team and proactive imaging-guided management are essential to optimize long-term outcomes for this challenging patient population.

  • Open Access

    Long-Term Prognosis Value of Paravalvular Leak and Patient–Prosthesis Mismatch following Transcatheter Aortic Valve Implantation: Insight from the France-TAVI Registry

    by Pierre Deharo, Lionel Leroux, Alexis Theron, Jérome Ferrara, Antoine Vaillier, Nicolas Jaussaud, Alizée Porto, Pierre Morera, Vlad Gariboldi, Bernard Iung, et al.

    Background: Transcatheter aortic valve implantation (TAVI) is the preferred treatment for symptomatic severe aortic stenosis (AS) in a majority of patients across all surgical risks. Patients and methods: Paravalvular leak (PVL) and patient–prosthesis mismatch (PPM) are two frequent complications of TAVI. Therefore, based on the large France-TAVI registry, we planned to report the incidence of both complications following TAVI, evaluate their respective risk factors, and study their respective impacts on long-term clinical outcomes, including mortality. Results: We identified 47,494 patients in the database who underwent a TAVI in France between 1 January 2010 and 31 December 2019. Within this population, 17,742 patients had information regarding PPM status (5138 with moderate-to-severe PPM, 29.0%) and 20,878 had information regarding PVL (4056 with PVL ≥ 2, 19.4%). After adjustment, the risk factors for PVL ≥ 2 were a lower body mass index (BMI), a high baseline mean aortic gradient, a higher body surface area, a lower ejection fraction, a smaller diameter of TAVI, and a self-expandable TAVI device, while for moderate-to-severe PPM we identified a younger age, a lower BMI, a larger body surface area, a low aortic annulus area, a low ejection fraction, and a smaller diameter TAVI device (OR 0.85; 95% CI, 0.83–0.86) as predictors. At 6.5 years, PVL ≥ 2 was an independent predictor of mortality and was associated with higher mortality risk. PPM was not associated with increased risk of mortality. Conclusions: Our analysis from the France-TAVI registry showed that both moderate-to-severe PPM and PVL ≥ 2 continue to be frequently observed after the TAVI procedure. Different risk factors, mostly related to the patient’s anatomy and TAVI device selection, for both complications have been identified. Only PVL ≥ 2 was associated with higher mortality during follow-up.


  • Open Access

    The illusion of a chest wall tumor: a case-report of sternal tuberculosis

    by Morgan Daniel, Charles Ricordel, Aurélien Lorleac'H, James Norwood, Bertrand Richard De Latour, Simon Rouzé, Jean-Philippe Verhoye

    The incidence rate of tuberculosis in developed countries is low. The most common presentation of this disease is its pulmonary form but with the increasing use of immunosuppressive drugs, extra-pulmonary tuberculosis is re-emerging. Nevertheless, sternal bone involvement is uncommon. We report the case of an eighty-three-year-old man who presented a painful sternal mass which progressed towards cutaneous ulceration. The first diagnostic hypothesis was neoplasia. The pathological and microbiological diagnosis of tuberculosis was achieved after surgical biopsy. The patient received treatment against tuberculosis for nine months enabling recovery without surgery. This case illustrates the importance of having a diagnosis prior to any kind of treatment facing any voluminous parietal thoracic lesions. This diagnosis is made possible by surgical samples and interdisciplinary teamwork. This case underlines that tuberculosis remains a differential diagnosis that must be evoked in case of unusual bone mass.


  • Neutrophil function and bactericidal activity againstStaphylococcus aureusafter cardiac surgery with cardiopulmonary bypass

    by Mathieu Lesouhaitier, Murielle Gregoire, Arnaud Gacouin, Valentin Coirier, Aurélien Frerou, Caroline Piau, Vincent Cattoir, Erwan Dumontet, Matthieu Revest, Pierre Tattevin, et al.

    Staphylococcus aureus is the main bacterial pathogen encountered in mediastinitis after cardiac surgical procedures; it remains a devastating complication with a high mortality rate. As neutrophils have a primordial role in the defense against staphylococcus infection and cardiopulmonary bypass (CPB) is known to induce immunosuppression, the aim of this study was to investigate CPB impact on neutrophil functions. Patients without known immunosuppression scheduled for cardiac surgery with CPB were included. Bone marrow and blood samples were harvested before, during, and after surgery. Neutrophil phenotypic maturation and functions (migration, adhesion, neutrophil extracellular trap [NET] release, reactive oxygen species (ROS) production, phagocytosis, and bacteria killing) were investigated. Two types of Staphylococcus aureus strains (one from asymptomatic nasal carriage and another from mediastinitis infected tissues) were used to assess in vitro bacterial direct impact on neutrophils. We found that CPB induced a systemic inflammation with an increase in circulating mature neutrophils after surgery. Bone marrow sample analysis did not reveal any modification of neutrophil maturation during CPB. Neutrophil lifespan was significantly increased and functions such as NET release and ROS production were enhanced after CPB whereas bacteria killing and phagocytosis were not impacted. Results were similar with the two different isolates of Staphylococcus aureus. These data suggest that CPB induces a recruitment of mature neutrophils via a demargination process rather than impacting their maturation in the bone marrow. In addition, neutrophils are fully efficient after CPB and do not contribute to postoperative immunosuppression.


  • Decision support system for the planning of minimally invasive aortic valve replacement surgery

    by Hui Li, Miguel Castro, Pascal Haigron, Jean-Philippe Verhoye, Vito Giovanni Ruggieri

    Minimally invasive aortic valve replacement (MIAVR) procedures remain more complex and technically challenging compared to conventional full sternotomy surgery. This technique involves a restricted surgical field and a limited workspace, which is, at present, strictly reserved for the most experienced surgeons. The MIAVR clinical outcomes are strongly dependent on the appropriate choice of the thoracic incision. This work presents a decision support system to optimize, through an interactive visualization interface, the exposure of the target structure in a limited field of view.


  • Open Access

    Elective frozen elephant trunk procedure using the E-Vita Open Plus prosthesis in 94 patients: a multicentre French registry

    by Jean-Philippe Verhoye, Reda Belhaj Soulami, Olivier Fouquet, Vito Giovanni Ruggieri, Adrien Kaladji, Jacques Tomasi, Michel Sellin, Fadi Farhat, Amedeo Anselmi

    OBJECTIVES: Our goal was to evaluate the operative outcomes of the frozen elephant trunk technique using the E-Vita Open Plus® hybrid prosthesis in chronic aortic arch diseases and report clinical and radiological outcomes at the 1-year follow-up. METHODS: As determined from a prospective multicentre registry, 94 patients underwent frozen elephant trunk procedures using the E-Vita Open Plus hybrid device for the treatment of chronic aortic conditions, including 50% chronic aortic dissections, 40% degenerative aneurysms and 10% miscellaneous indications. Fifty percent of the cases were reoperations. RESULTS: The perioperative mortality rate was 11.7%. Spinal cord ischaemia and stroke rates were 4% and 9.6%, respectively. The mean cardiopulmonary bypass time was 252 ± 97 min, cardiac ischaemia time was 152 ± 53 min and cerebral perfusion time was 82 ± 22 min. Concomitant procedures were observed in 15% of patients. Among the 83 surviving patients, the survival rate after the 1-year follow-up was 98%. Eleven percent of patients underwent endovascular completion, whereas 4% of patients required aortic reintervention at 1 year. CONCLUSIONS: The E-Vita Open Plus hybrid device confirms the favourable short- and mid-term outcomes offered by its predecessor in frozen elephant trunk procedures in patients with chronic aortic arch disease. Implantation of the E-Vita Open Plus is associated with good 1-year survival rates, good rates of favourable aortic remodelling in both chronic dissection and degenerative aneurysms and a reproducible technique in a multicentre registry. Continued follow-up is required due to the risk of evolution at the downstream aorta.


  • 0418: Comparison of pre- and post-operative characteristics in octogenarians having isolated surgical aortic valve replacement before versus after introduction of transcatheter aortic valve implantation

    by Moukda Khounlaboud, Erwan Donal, Vincent Auffret, Anne Ingels, Erwan Flécher, Jean-Philippe Verhoye, Jean-Claude Daubert, Hervé le Breton, Philippe Mabo, Alain Leguerrier

    • 1 July 2015
      • Vol. 24  (4) , 484-6

    Feasibility of Valve-in-Valve Procedure for Degenerated St. Jude Medical Trifecta Bioprosthesis.

    by Jean-Philippe Verhoye, Majid Harmouche, Reda Belhaj Soulami, Christophe Thebault, Dominique Boulmier, Alain Leguerrier, Amedeo Anselmi

    The valve-in-valve (ViV) procedure is an option for patients with symptomatic structural degeneration of a bioprosthesis and excessive reoperative risk. The risk of coronary obstruction appears to be increased if ViV is performed for certain pericardial prostheses in which the leaflets are mounted outside the stent posts. Herein is described a successful ViV for a degenerated Trifecta aortic bioprosthesis, and the technical considerations for performing a ViV procedure within such types of prosthesis are considered. Emphasis is placed on the importance of preoperative investigations (computed tomography scan-based measurements of coronary ostial height and of sinus of Valsalva diameters), and on the precise deployment of the valve (transapical approach with transesophageal echocardiography control) to minimize the risk of major complications. The presence of a failing Trifecta bioprosthesis should not be considered an absolute contraindication to ViV on the basis of the risk of coronary obstruction.

  • De FRANCE 2 à FRANCE TAVI : les indications, la technique et les résultats du remplacement valvulaire aortique percutané sont-ils les mêmes ?

    by Vincent Auffret, Marc Bedossa, Dominique Boulmier, Jean Philippe Verhoye, Vito Giovanni Ruggieri, René Koning, Marc Laskar, Éric Van Belle, Pascal Leprince, Jean Philippe Collet, et al.


  • Is the EuroSCORE II best suited for reoperative risk estimation in patients with structural deterioration of aortic bioprostheses?

    by Amedeo Anselmi, Vito Giovanni Ruggieri, Majid Harmouche, Sophie Mascle, Vincent Auffret, Hervé Le Breton, Xavier Beneux, Jean-Philippe Verhoye